Return On Equity in % of ELITE PHARMACEUTICALS INC /NV/ from Q4 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly/annual Return On Equity history and change rate from Q4 2011 to Q3 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Return On Equity for the quarter ending 30 Sep 2025 was 28 %.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Equity for 2024 was -9.63 %, a 113% decline from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Equity for 2023 was 71.9 %, a 340% increase from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Return On Equity for 2022 was 16.3 %, a 72.8% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 28 +40.2 01 Jul 2025 30 Sep 2025
Q2 2025 -23.4 -61.2 -162% 01 Apr 2025 30 Jun 2025
Q1 2025 -8.83 -53.7 -120% 01 Jan 2025 31 Mar 2025
Q4 2024 -36.1 -77.4 -187% 01 Oct 2024 31 Dec 2024
Q3 2024 -12.2 -65.2 -123% 01 Jul 2024 30 Sep 2024
Q2 2024 37.8 +22.7 +150% 01 Apr 2024 30 Jun 2024
Q1 2024 44.9 +32.2 +252% 01 Jan 2024 31 Mar 2024
Q4 2023 41.3 +14.6 +54.7% 01 Oct 2023 31 Dec 2023
Q3 2023 53.1 +27.1 +105% 01 Jul 2023 30 Sep 2023
Q2 2023 15.1 -13.9 -47.9% 01 Apr 2023 30 Jun 2023
Q1 2023 12.7 -28.1 -68.8% 01 Jan 2023 31 Mar 2023
Q4 2022 26.7 -3.93 -12.8% 01 Oct 2022 31 Dec 2022
Q3 2022 25.9 -5.82 -18.3% 01 Jul 2022 30 Sep 2022
Q2 2022 29 -9.74 -25.1% 01 Apr 2022 30 Jun 2022
Q1 2022 40.8 +6.42 +18.7% 01 Jan 2022 31 Mar 2022
Q4 2021 30.6 -17.8 -36.8% 01 Oct 2021 31 Dec 2021
Q3 2021 31.8 +8.92 +39.1% 01 Jul 2021 30 Sep 2021
Q2 2021 38.7 +59 01 Apr 2021 30 Jun 2021
Q1 2021 34.4 +94.9 01 Jan 2021 31 Mar 2021
Q4 2020 48.5 +1.46K 01 Oct 2020 31 Dec 2020
Q3 2020 22.8 -306 -93.1% 01 Jul 2020 30 Sep 2020
Q2 2020 -20.3 -1.04K -102% 01 Apr 2020 30 Jun 2020
Q1 2020 -60.5 +1.72K +96.6% 01 Jan 2020 31 Mar 2020
Q4 2019 -1.41K -1K -243% 01 Oct 2019 31 Dec 2019
Q3 2019 329 +526 01 Jul 2019 30 Sep 2019
Q2 2019 1.02K +1.09K 01 Apr 2019 30 Jun 2019
Q1 2019 -1.78K -1.71K -2387% 01 Jan 2019 31 Mar 2019
Q4 2018 -412 -373 -964% 01 Oct 2018 31 Dec 2018
Q3 2018 -197 -185 -1521% 01 Jul 2018 30 Sep 2018
Q2 2018 -64.4 -67.2 -2379% 01 Apr 2018 30 Jun 2018
Q1 2018 -71.6 -107 -303% 01 Jan 2018 31 Mar 2018
Q4 2017 -38.7 +362 +90.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -12.1 -5.86 -93.3% 01 Jul 2017 30 Sep 2017
Q2 2017 2.82 -8.72 -75.5% 01 Apr 2017 30 Jun 2017
Q1 2017 35.3 +33.3 +1693% 01 Jan 2017 31 Mar 2017
Q4 2016 -400 -444 -1005% 01 Oct 2016 31 Dec 2016
Q3 2016 -6.28 +8.62 +57.8% 01 Jul 2016 30 Sep 2016
Q2 2016 11.5 +45.8 01 Apr 2016 30 Jun 2016
Q1 2016 1.97 +12.2 01 Jan 2016 31 Mar 2016
Q4 2015 44.2 -75.4 -63% 01 Oct 2015 31 Dec 2015
Q3 2015 -14.9 -163 -110% 01 Jul 2015 30 Sep 2015
Q2 2015 -34.2 -260 -115% 01 Apr 2015 30 Jun 2015
Q1 2015 -10.2 -403 -103% 01 Jan 2015 31 Mar 2015
Q4 2014 120 -6.95 -5.49% 01 Oct 2014 31 Dec 2014
Q3 2014 148 +175 01 Jul 2014 30 Sep 2014
Q2 2014 226 +331 01 Apr 2014 30 Jun 2014
Q1 2014 393 +402 01 Jan 2014 31 Mar 2014
Q4 2013 127 +87.3 +222% 01 Oct 2013 31 Dec 2013
Q3 2013 -27 -68.4 -165% 01 Jul 2013 30 Sep 2013
Q2 2013 -105 -78.1 -289% 01 Apr 2013 30 Jun 2013
Q1 2013 -8.99 -74.6 -114% 01 Jan 2013 31 Mar 2013
Q4 2012 39.3 -64.9 -62.3% 01 Oct 2012 31 Dec 2012
Q3 2012 41.5 01 Jul 2012 30 Sep 2012
Q2 2012 -27 01 Apr 2012 30 Jun 2012
Q1 2012 65.6 01 Jan 2012 31 Mar 2012
Q4 2011 104 01 Oct 2011 31 Dec 2011

ELITE PHARMACEUTICALS INC /NV/ Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -9.63 -81.5 -113% 01 Apr 2024 31 Mar 2025
2023 71.9 +55.6 +340% 01 Apr 2023 31 Mar 2024
2022 16.3 -43.8 -72.8% 01 Apr 2022 31 Mar 2023
2021 60.1 -77.2 -56.2% 01 Apr 2021 31 Mar 2022
2020 137 +567 01 Apr 2020 31 Mar 2021
2019 -430 -249 -138% 01 Apr 2019 31 Mar 2020
2018 -181 -147 -433% 01 Apr 2018 31 Mar 2019
2017 -33.9 -23 -209% 01 Apr 2017 31 Mar 2018
2016 -11 -12.3 -924% 01 Apr 2016 31 Mar 2017
2015 1.33 +22.6 01 Apr 2015 31 Mar 2016
2014 -21.2 -271 -109% 01 Apr 2014 31 Mar 2015
2013 249 +256 01 Apr 2013 31 Mar 2014
2012 -6.48 01 Apr 2012 31 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.